Market Live: Sensex off opening high, Nifty breaks 10,100; Infosys, Biocon rally

Biocon surged 10 percent as the US FDA approved Mylan and Biocon#39;s Ogivri, the first biosimilar for Trastuzumab, for the Treatment of HER2-Positive...